Brightside Health secures $33 million in Series C funding

The article discusses how telemental health company Brightside Health has successfully raised $33 million in Series C funding from venture capital firm S32, with participation from notable investors such as Kennedy Lewis, Time BioVentures, and Anne Wojcicki. The company has now raised a total of $100 million, and has added former Optum Behavioral Health Solutions CEO Trip Hofer to its board of directors. Brightside Health provides care for individuals suffering from anxiety, depression, and other mood disorders through its Crisis Care psychiatry platform, utilizing a machine-learning algorithm to tailor treatment plans. This funding will be used to expand into new markets, including Medicare and Medicaid.

Highlights of the article:
1. Brightside Health raises $33 million in Series C funding led by S32, with participation from several prominent investors.
2. The company has raised a total of $100 million and added Trip Hofer to its board of directors.
3. Brightside Health offers telehealth services for individuals with anxiety, depression, and other mood disorders, using technology and AI to personalize treatment plans.

In summary, Brightside Health’s successful funding round will enable the company to further expand its telehealth services for mental health care and reach new markets. With a focus on utilizing technology and machine learning to personalize treatment options, Brightside Health aims to provide effective care for those suffering from various mental health conditions.

Editorial content by NewsSIP AI